Similarly, two consecutive studies by Toricelli et al. validated these findings, revealing that inhibition of PI3K or Akt proteins reversed anoikis resistance in melanoma cells (Toricelli et al., 2013; Toricelli et al., 2017). Here, AKT1 is linked to melanoma.